Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy

ABSTRACTIntroduction: The success of CD19 chimeric antigen receptor (CAR)-T cell therapy for treatment of CD19 positive malignancies has led to the FDA approval of two CD19 CAR-T cell products, tis...